326
Views
7
CrossRef citations to date
0
Altmetric
Original Articles: Clinical

Expression patterns of CD33 and CD15 predict outcome in patients with acute myeloid leukemia

, , , &
Pages 1279-1291 | Received 11 Sep 2007, Accepted 12 Apr 2008, Published online: 01 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Liurui Dou, Mingyue Shi, Juanjuan Song, Xiaona Niu, Junwei Niu, Shengjie Wei, Dan Li, Yanliang Bai & Kai Sun. (2022) The Prognostic Significance of C-Reactive Protein to Albumin Ratio in Newly Diagnosed Acute Myeloid Leukaemia Patients. Cancer Management and Research 14, pages 303-316.
Read now

Articles from other publishers (5)

Jianai Sun, Jingjing Zhu, De Zhou, Lixia Zhu, Xiudi Yang, Mixue Xie, Li Li, Xianbo Huang, Mingyu Zhu, Yanlong Zheng, Wanzhuo Xie & Xiujin Ye. (2019) Factors Affecting Early Death and Survival of Patients With Acute Promyelocytic Leukemia Treated With ATRA-Based Therapy Regimens. Clinical Lymphoma Myeloma and Leukemia 19:1, pages e63-e70.
Crossref
Martín E. Rabassa, Adrian Pereyra, Liliana Pereyra, Amada Segal-Eiras, Martín C. Abba & Maria V. Croce. (2017) Lewis x Antigen is Associated to Head and Neck Squamous Cell Carcinoma Survival. Pathology & Oncology Research 24:3, pages 525-531.
Crossref
Debmalya Barh, Angelo Carpi, Mukesh Verma & Mehmet GunduzOta Fuchs. 2014. Cancer Biomarkers. Cancer Biomarkers 813 848 .
Stefanie Slezak, Ping Jin, Lorraine Caruccio, Jiaqiang Ren, Michael Bennett, Nausheen Zia, Sharon Adams, Ena Wang, Joao Ascensao, Geraldine Schechter & David Stroncek. (2009) Gene and microRNA analysis of neutrophils from patients with polycythemia vera and essential thrombocytosis: down-regulation of micro RNA-1 and -133a. Journal of Translational Medicine 7:1.
Crossref
. (2008) Current Awareness in Hematological Oncology. Hematological Oncology 26:4, pages 253-260.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.